Eva Maria Wagner-Drouet (Eva Wagner, Eva-Maria Wagner, Eva Wagner-Drouet, Eva Marie Wagner-Drouet, Eva-Maria Wagner-Drouet)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 36

Top Topics

Acute Myeloid Leukemia

Allogeneic Hematopoietic Stem Cell Transplantation

Top Venues

Bone marrow transplantation

Annals of hematology

This page only lists publications with an associated author ORCID identifier.

Publications

Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Urban Novak, Jarl E Mooyaart, Michael Daskalakis, Christof Scheid, Ludovic Gabellier, Ibrahim Yakoub-Agha, Ron Ram, Edouard Forcade, Lucía López-Corral, Emma Nicholson, Eugenio Galli, Friedrich Stölzel, Wolfgang Andreas Bethge, Eva Maria Wagner-Drouet, Jorinde D Hoogenboom, Stephan Mielke, Caroline Arber, Federico Simonetta, Christian Chabanon, Jürgen H E Kuball, Annalisa Ruggeri, Florent Malard
Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT. Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Francis A Ayuk, Eva Maria Wagner-Drouet, Daniel Wolff, Natascha von Huenerbein, Ute-Marie von Pein, Evgeny Klyuchnikov, Stephanie von Harsdorf, Christian Koenecke, Herbert Sayer, Nicolaus Kröger
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study. Bone marrow transplantation 59 (8) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Olivier Tournilhac, Bettina Altmann, Birte Friedrichs, Kamal Bouabdallah, Mathieu Leclerc, Guillaume Cartron, Pascal Turlure, Peter Reimer, Eva Maria Wagner-Drouet, Laurence Sanhes, Houot Roch, Murielle Roussel, Frank Kroschinsky, Peter Dreger, Andreas Viardot, Laurence L de Leval, Andreas Rosenwald, Philippe Gaulard, Gerald Georg Wulf, Alban Villate, Christelle Latiere, Ahmet Elmaagacli, Bertram Glass, Viola Poeschel, Gandhi Laurent Damaj, David Sibon, Eric Durot, Karin Bilger, Anne Banos, Mathias Haenel, Martin Dreyling, Ulrich Bernd Keller, Mourad Tiab, Bernard Drénou, Jérome Cornillon, Stéphanie Nguyen, Marie Robin, Maike Nickelsen, Lorenz Trümper, Georg Lenz, Marita Ziepert, Norbert Schmitz, null null, null null, null null, null null
Long-Term Follow-Up of the Prospective Randomized AATT Study (Autologous or Allogeneic Transplantation in Patients With Peripheral T-Cell Lymphoma). Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer 5 (8) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Correction: Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer 5 (8) (2024)
Francis A Ayuk, Eva Maria Wagner-Drouet, Daniel Wolff, Natascha von Huenerbein, Ute-Marie von Pein, Evgeny Klyuchnikov, Stephanie von Harsdorf, Christian Koenecke, Herbert Sayer, Nicolaus Kröger
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study. Bone marrow transplantation 59 (8) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Francis A Ayuk, Eva Maria Wagner-Drouet, Daniel Wolff, Natascha von Huenerbein, Ute-Marie von Pein, Evgeny Klyuchnikov, Stephanie von Harsdorf, Christian Koenecke, Herbert Sayer, Nicolaus Kröger
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study. Bone marrow transplantation 59 (8) (2024)
Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Dominik Schmidt, Viktor Fetsch, Alexander Zähringer, Henrike Salié, Dimitrios Athanassopoulos, Lukas M Braun, Nora R Javorniczky, Jenny N H G Ho, Katrin Kierdorf, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian M Capitini, Terry J Fry, Thomas Blank, Bruce R Blazar, Eva Maria Wagner-Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, Klaus Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp T Meyer, Joachim Brumberg, Simon Völkl, Andreas Mackensen, Roland Coras, Michael von Bergwelt-Baildon, Nathalie L Albert, Laura M Bartos, Matthias Brendel, Adrien Holzgreve, Matthias Mack, Melanie Börries, Crystal L Mackall, Justus Duyster, Philipp Henneke, Josef Priller, Natalie Stickel, Felix L Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndrome. Nature cancer (2024)
Francis A Ayuk, Eva Maria Wagner-Drouet, Daniel Wolff, Natascha von Huenerbein, Ute-Marie von Pein, Evgeny Klyuchnikov, Stephanie von Harsdorf, Christian Koenecke, Herbert Sayer, Nicolaus Kröger
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study. Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation 59 (5) (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter obervational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation 59 (7) (2024)
Dietrich Wilhelm Beelen, Simona Iacobelli, Linda Koster, Dirk-Jan Eikema, Anja van Biezen, Friedrich Stölzel, Fabio Ciceri, Wolfgang Andreas Bethge, Peter Dreger, Eva Maria Wagner-Drouet, Péter Reményi, Matthias Stelljes, Miroslaw Markiewicz, Donal P McLornan, Ibrahim Yakoub-Agha, Florent Malard
Fludarabine-treosulfan versus fludarabine-melphalan or busulfan-cyclophosphamide conditioning in older AML or MDS patients - A clinical trial to registry data comparison. Bone marrow transplantation (2024)
Juergen Finke, Claudia Schmoor, Francis A Ayuk, Justin Hasenkamp, Mareike Verbeek, Eva Maria Wagner-Drouet, Harald Biersack, Kerstin Schäfer-Eckart, Dominik Wolf, Gernot Stuhler, Roland Reibke, Christoph Schmid, Martin Kaufmann, Matthias Eder, Hartmut Bertz, Olga Grishina
Long term results of a prospective multicenter observational study on the use of anti-human T-lymphocyte immunoglobulin (ATLG) in unrelated donor transplantation (ATOS study). Bone marrow transplantation (2024)
Andreas Mackensen, John B A G Haanen, Christian Koenecke, Winfried Alsdorf, Eva Maria Wagner-Drouet, Peter Borchmann, Daniel Heudobler, Barbara Ferstl, Sebastian Klobuch, Carsten Bokemeyer, Alexander Desuki, Florian Lüke, Nadine Kutsch, Fabian Müller, Eveline Smit, Peter Hillemanns, Panagiotis Karagiannis, Erol Wiegert, Ying He, Thang Ho, Qing Kang-Fortner, Anna Melissa Schlitter, Catrine Schulz-Eying, Andrew Finlayson, Carina Flemmig, Klaus Kühlcke, Liane Preußner, Benjamin Rengstl, Özlem Türeci, Uğur Şahin
CLDN6-specific CAR-T cells plus amplifying RNA vaccine in relapsed or refractory solid tumors: the phase 1 BNT211-01 trial. Nature medicine (2023)
Philipp Berning, Norbert Schmitz, Maud Ngoya, Hervé Finel, Ariane Boumendil, Fengrong Wang, Xiao-Jun Huang, Olivier Hermine, Laure Philippe, Lucile Couronné, Arnaud Jaccard, Dai-Hong Liu, Depei Wu, Hans Christian Reinhardt, Yves Chalandon, Eva Maria Wagner-Drouet, Mi Kwon, Xi Zhang, Ben Carpenter, Ibrahim Yakoub Agha, Gerald Wulf, Javier López-Jiménez, Jaime Sanz, Hélène Labussière-Wallet, Avichai Shimoni, Peter Dreger, Anna Sureda, Won Seog Kim, Bertram Glass
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis. Leukemia (2023)
Philipp Berning, Norbert Schmitz, Maud Ngoya, Hervé Finel, Ariane Boumendil, Fengrong Wang, Xiao-Jun Huang, Olivier Hermine, Laure Philippe, Lucile Couronné, Arnaud Jaccard, Dai-Hong Liu, Depei Wu, Hans Christian Reinhardt, Yves Chalandon, Eva Maria Wagner-Drouet, Mi Kwon, Xi Zhang, Ben Carpenter, Ibrahim Yakoub Agha, Gerald Wulf, Javier López-Jiménez, Jaime Sanz, Hélène Labussière-Wallet, Avichai Shimoni, Peter Dreger, Anna Sureda, Won Seog Kim, Bertram Glass
Allogeneic hematopoietic stem cell transplantation for NK/T-cell lymphoma: an international collaborative analysis. Leukemia (2023)
Maria-Luisa Schubert, Wolfgang Andreas Bethge, Francis Ayuketang Ayuk, Malte von Bonin, Vladan Vucinic, Eva Maria Wagner-Drouet, Marion Subklewe, Claudia D Baldus, Bertram Glass, Reinhard Marks, Dimitrios Mougiakakos, Roland Schroers, Matthias Stelljes, Max S Topp, Gerald Georg Wulf, Nicolaus M Kröger, Peter Dreger
Outcomes of axicabtagene ciloleucel in PMBCL compare favorably to DLBCL: a GLA/DRST registry study. Blood advances (2023)
Jesus Duque-Afonso, Juergen Finke, Maud Ngoya, Jacques-Emmanuel Galimard, Charles F Craddock, Kavita Raj, Adrian Bloor, Emma Nicholson, Matthias Eder, Orchard Kim, Thomas Valerius, John A Snowden, Eleni Tholouli, Charles Crawley, Matthew Collin, Keith M O Wilson, Alain Gadisseur, Rachel Protheroe, Eva Maria Wagner-Drouet, Bipin P Savani, Alexandros Spirydonidis, Fabio Ciceri, Arnon Nagler, Florent Malard
Comparison of fludarabine/melphalan (FluMel) with fludarabine/melphalan/BCNU or thiotepa (FBM/FTM) in patients with AML in first complete remission undergoing allogeneic hematopoietic stem cell transplantation - a registry study on behalf of the EBMT Acute Leukemia Working Party. Bone marrow transplantation (2023)
Oliver Kriege, Andreas Kreft, Beate Hauptrock, Pascal Wölfinger, Matthias Theobald, Eva Maria Wagner-Drouet
Diagnosis of sinusoidal obstruction syndrome: can biopsy be the key? Annals of hematology (2023)
Alexandros Spirydonidis, Myriam Labopin, Tobias Gedde-Dahl, Arnold Ganser, Matthias Stelljes, Charles F Craddock, Eva Maria Wagner-Drouet, Jurjen Versluis, Thomas Schroeder, Igor Wolfgang Blau, Gerald G Wulf, Peter Dreger, Gitte Olesen, Henrik Sengeloev, Nicolaus M Kröger, Victoria Potter, Edouard Forcade, Jakob R Passweg, Régis Peffault de Latour, Johan A Maertens, Keith M O Wilson, Jean Henri Bourhis, Juergen Finke, Eolia Brissot, Ali Bazarbachi, Sebastian Giebel, Bipin P Savani, Arnon Nagler, Fabio Ciceri, Florent Malard
Validation of the transplant conditioning intensity (TCI) index for allogeneic hematopoietic cell transplantation. Bone marrow transplantation (2023)
Wolfgang Andreas Bethge, Peter Martus, Michael Schmitt, Udo Holtick, Marion Subklewe, Bastian von Tresckow, Francis Ayuk, Eva Maria Wagner-Drouet, Gerald G Wulf, Reinhard Marks, Olaf Penack, Ulf Schnetzke, Christian Koenecke, Malte von Bonin, Matthias Stelljes, Bertram Glass, Claudia D Baldus, Vladan Vucinic, Dimitrios Mougiakakos, Max Topp, Matthias A Fante, Roland Schroers, Lale Bayir, Peter Borchmann, Veit L Bücklein, Justin Hasenkamp, Christine Hanoun, Simone Thomas, Dietrich W Beelen, Claudia Lengerke, Nicolaus Kroeger, Peter Dreger
GLA/DRST real-world outcome analysis of CAR T-cell therapies for large B-cell lymphoma in Germany. Blood 140 (4) (2022)
Justin Loke, Myriam Labopin, Charles Craddock, Jan J Cornelissen, Hélène Labussière-Wallet, Eva Maria Wagner-Drouet, Gwendolyn Van Gorkom, Nicolaas P M Schaap, Nicolaus M Kröger, Joan Hendrik Veelken, Montserrat Rovira, Anne Lise Menard, Gesine Bug, Ali Bazarbachi, Sebastian Giebel, Eolia Brissot, Arnon Nagler, Jordi Esteve, Mohamad Mohty
Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia. Cancer 128 (15) (2022)